Registration Strip Icon for monitor 브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.

MRVI

Maravai LifeSciences (MRVI)

Maravai LifeSciences Holdings Inc
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:MRVI
일자시간출처헤드라인심볼기업
2024/05/1321:00Business WireTriLink BioTechnologies collaborates with Johns Hopkins University to establish a new RNA Innovation CenterNASDAQ:MRVIMaravai LifeSciences Holdings Inc
2024/05/1005:44Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:MRVIMaravai LifeSciences Holdings Inc
2024/05/1005:05GlobeNewswire Inc.Maravai LifeSciences Announces May and June 2024 Investor Conference ScheduleNASDAQ:MRVIMaravai LifeSciences Holdings Inc
2024/05/0905:09Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MRVIMaravai LifeSciences Holdings Inc
2024/05/0905:05GlobeNewswire Inc.Maravai LifeSciences Reports First Quarter 2024 Financial ResultsNASDAQ:MRVIMaravai LifeSciences Holdings Inc
2024/05/0105:49Business WireTriLink BioTechnologies® et Lonza signent un contrat de licence et d'approvisionnement non exclusif pour la technologie de capsulage d'ARNm CleanCap®NASDAQ:MRVIMaravai LifeSciences Holdings Inc
2024/05/0105:49Business WireTriLink BioTechnologies® und Lonza schließen nicht-exklusiven Lizenz- und Liefervertrag für CleanCap® mRNA Capping Technologie abNASDAQ:MRVIMaravai LifeSciences Holdings Inc
2024/04/3020:31Business WireTriLink BioTechnologies® and Lonza Enter into Non-exclusive License and Supply Agreement for CleanCap® mRNA Capping TechnologyNASDAQ:MRVIMaravai LifeSciences Holdings Inc
2024/04/1904:12Business WireTriLink BioTechnologies® annonce un nouveau site à San Diego pour la production de substances médicamenteuses à base d'ARNm au stade ultime de leur développementNASDAQ:MRVIMaravai LifeSciences Holdings Inc
2024/04/1904:09Business WireTriLink BioTechnologies® kündigt neue Anlage in San Diego zur mRNA-Produktion von Arzneimittelwirkstoffen in der Spätphase anNASDAQ:MRVIMaravai LifeSciences Holdings Inc
2024/04/1820:36Business WireTriLink BioTechnologies® Announces New San Diego Facility for Late Phase mRNA Drug Substance ProductionNASDAQ:MRVIMaravai LifeSciences Holdings Inc
2024/04/1105:05GlobeNewswire Inc.Maravai LifeSciences To Host Earnings Conference Call on Wednesday, May 8, 2024NASDAQ:MRVIMaravai LifeSciences Holdings Inc
2024/03/1305:15GlobeNewswire Inc.Maravai LifeSciences Announces March 2024 Investor Conference ScheduleNASDAQ:MRVIMaravai LifeSciences Holdings Inc
2024/03/0107:05Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:MRVIMaravai LifeSciences Holdings Inc
2024/02/2306:08Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MRVIMaravai LifeSciences Holdings Inc
2024/02/2306:05GlobeNewswire Inc.Maravai LifeSciences Reports Fourth Quarter and Full Year 2023 Financial ResultsNASDAQ:MRVIMaravai LifeSciences Holdings Inc
2024/02/2122:00Business WireTriLink BioTechnologies® Solidifies IP Position with Awarded Patents for CleanCap® Capping Technology in China and CanadaNASDAQ:MRVIMaravai LifeSciences Holdings Inc
2024/02/2108:47Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MRVIMaravai LifeSciences Holdings Inc
2024/02/1322:30GlobeNewswire Inc.Dyadic and Cygnus Technologies Announce Partnership To Provide C1 HCP ELISA Assay to Enhance Quality Assurance in BiomanufacturingNASDAQ:MRVIMaravai LifeSciences Holdings Inc
2024/02/0906:45Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:MRVIMaravai LifeSciences Holdings Inc
2024/01/2922:00GlobeNewswire Inc.Maravai LifeSciences To Host Earnings Conference Call on Thursday, February 22, 2024NASDAQ:MRVIMaravai LifeSciences Holdings Inc
2024/01/1908:32Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MRVIMaravai LifeSciences Holdings Inc
2024/01/1908:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MRVIMaravai LifeSciences Holdings Inc
2024/01/1908:28Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MRVIMaravai LifeSciences Holdings Inc
2024/01/1908:20Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MRVIMaravai LifeSciences Holdings Inc
2024/01/1908:15Edgar (US Regulatory)Form 5 - Annual statement of changes in beneficial ownership of securitiesNASDAQ:MRVIMaravai LifeSciences Holdings Inc
2023/11/1707:21Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MRVIMaravai LifeSciences Holdings Inc
2023/11/0922:15GlobeNewswire Inc.Maravai LifeSciences Announces November 2023 Investor Conference ScheduleNASDAQ:MRVIMaravai LifeSciences Holdings Inc
2023/11/0907:28Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:MRVIMaravai LifeSciences Holdings Inc
2023/11/0806:11Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MRVIMaravai LifeSciences Holdings Inc
 검색 관련기사 보기:NASDAQ:MRVI

최근 히스토리

Delayed Upgrade Clock